-
Mashup Score: 0Eisai prepares to share more findings for lecanemab - 1 year(s) ago
Eisai is preparing to share efficacy, safety and biomarker findings from its Phase 3 study of the amyloid beta-protein inhibitor lecanemab.
Source: Drug Discovery and DevelopmentCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 8AstraZeneca's Susan Galbraith has helped develop 7 blockbusters - 2 year(s) ago
Dr. Susan Galbraith, EVP of oncology R&D at AstraZeneca, says her entry into the pharmaceutical industry was serendipitous.
Source: Drug Discovery and DevelopmentCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0
Where would clinical trial diversity be without the COVID-19 pandemic and the death of George Floyd on May 25, 2020? | Drug Discovery
Source: Drug Discovery and DevelopmentCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Pfizer and BioNTech are seeking an EUA to use their vaccine in children aged six months to four years of age. | Drug Discovery & Development
Source: Drug Discovery and DevelopmentCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0How psychedelics might address unmet need in mental health | DDD - 2 year(s) ago
Part of the reason for the recent interest in psychedelics is their potential to address difficult-to-treat mental health conditions.
Source: Drug Discovery and DevelopmentCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Moderna says its mRNA Access program could help with the next pandemic - Drug Discovery and Development - 2 year(s) ago
The program enables researchers to use Moderna’s mRNA technology for research projects related to emerging and neglected infectious diseases.
Source: Drug Discovery and DevelopmentCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0J&J and Roche named to Clarivate’s Top 100 Global Innovators list - Drug Discovery and Development - 2 year(s) ago
Few healthcare companies were included in the annual ranking of innovative companies from the analytics firm Clarivate plc (NYSE:CLVT).
Source: Drug Discovery and DevelopmentCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0New AI out of MIT predicts how proteins will attach - Drug Discovery and Development - 2 year(s) ago
MIT researchers are touting a machine learning model that can predict the complex that will form when proteins bind together.
Source: Drug Discovery and DevelopmentCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2Decentralized clinical trials can have big financial upside, study finds - Drug Discovery and Development - 2 year(s) ago
Medable has announced that DCTs can accelerate clinical trial timelines and lead to significant cost savings.
Source: Drug Discovery and DevelopmentCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Researchers are now exploring dozens of new applications of the mRNA platform, which range from cancer to the Zika virus.
Source: Drug Discovery and DevelopmentCategories: Healthcare Professionals, Latest HeadlinesTweet
Sermo’s recent survey found that 69% of physicians believe the incremental benefit of lecanemab could have unintended consequences, prolonging the hardships for Alzheimer’s patients. Check out the full article here: https://t.co/KfVuUKhQiO